| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |